Skip to main content
. 2020 Feb;8(4):95. doi: 10.21037/atm.2019.12.152

Table 5. Quality assessment of RCTs.

Study Random sequence generation Allocation concealment Blinding of participants and personnel Blinding of outcome assessment Incomplete outcome data Selective reporting Other bias
SELECT-D Low Low High Low Low Low Low
Hokusai VTE Cancer Low Unclear High Low Low Low Low
AMPLIFY Low Low Low Low Low Low Low
EINSTEIN-PE/DVT Low Unclear High Low Low Low Low
Hokusai-VTE Low Unclear Low Low Low Low Low
RECOVER-I/II Low Low Low Low Low Low Low

RCT, randomized controlled trial; Low, low risk; unclear, unclear risk; High, high risk.